Anti-Human Desmoglein-3-Anti-Human Desmoglein-3-一抗-艾美捷科技有限公司

PRODUCT CENTER

一抗

产品中心

当前位置：首页 > 产品中心 > 免疫学产品 > 一抗

背景资料: Desmoglein3, also known as pemphigus vulgaris antigen (PVA), is a 130 kDa transmembrane glycoprotein that belongs to the cadherin family of calcium dependent adhesion molecules. Human Desmoglein3 is synthesized with a 26 amino acid (aa) propeptide. The mature protein consists of a 566 aa extracellular domain (ECD) that contains four cadherinlike domains, a 25 aa transmembrane segment, and a 359 aa cytoplasmic domain. Within the ECD, human Desmoglein3 shares 78% aa sequence identity with mouse and rat Desmoglein3. It shares 44%, 47%, and 56% aa sequence identity with Desmoglein1, 2, and 4 respectively. Desmoglein3 is one of the principal components of desmosomes which form adhesive contacts between epithelial cells. It is expressed in the basal and suprabasal layers of stratified epithelia in many tissues. During apoptosis, Desmoglein3 is cleaved by caspases, plus MMP2, and MMP9 at sites within the cytoplasmic and extracellular regions, resulting in shortened transmembrane forms and a soluble 75 kDa ECD fragment. The downregulation of Desmoglein3 in oral squamous cell carcinoma correlates with metastatic potential. Desmoglein3 is the target of autoantibodies in pemphigus vulgaris, a blistering skin disorder with compromised interkeratinocyte adhesion. Binding of these antibodies triggers Desmoglein3 internalization and degradation by keratinocytes.

保存建议: 该Anti-Human Desmoglein-3的详细信息查看ReliaTech提供的产品说明书。溶解建议：Centrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.

其他: ReliaTech全称为受体配体技术有限公司 (Receptor Ligand Technologies GmbH)，1999年成立，总部位于德国不伦瑞克，是一家后基因组生物技术公司。ReliaTech主要专注于受体和配体的发现与研究。此外，ReliaTech也开发应用于血管与淋巴管生成研究的相关高品质试剂。目前ReliaTech提供近2800款产品，产品线主要包括重组蛋白(细胞因子、生长因子、可溶性受体)、抗体、ELISA试剂盒等。